Australian MPs Admit They Tried Cannabis, Signaling Policy Reform & Epidiolex For Seizures Approved In Canada
Portfolio Pulse from Jelena Martinovic
Australian officials, including Victoria's Premier and Treasurer, have admitted to past cannabis use, signaling a potential shift towards decriminalizing cannabis for personal use. A bill introduced by the Legalise Cannabis Party aims to legalize personal cannabis use, but the Labor government is currently unable to support it in its existing form. In New South Wales, a measure could allow individuals to gift cannabis, grow plants, and possess up to 50 grams. However, the Australian Medical Association opposes recreational legalization due to health risks. Separately, Jazz Pharmaceuticals' Epidiolex, a CBD oral solution, has been approved by Health Canada for treating seizures associated with certain syndromes in patients 2 years and older.
November 30, 2023 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jazz Pharmaceuticals' CBD oral solution, Epidiolex, has been approved by Health Canada for treating seizures associated with certain syndromes, potentially expanding its market.
The approval of Epidiolex in Canada is a significant milestone for Jazz Pharmaceuticals, likely to have a positive impact on the company's stock in the short term due to the expansion of its market and the reaffirmation of its commitment to cannabinoid-based medicines.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90